Clinical trial
Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell…
NCT00004225 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00004225 |
|---|---|
| Title | Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer |
| Official title | Phase I Pilot Trial of Adenovirus p53 and Radiotherapy on Nonsmall Cell Lung Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Radiation |
| Interventions | Ad5CMV-p53 gene, radiation therapy |
| Start date | Jan 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 7, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: